Peter Evans
Impact in
- Biotechnology top 2%
- Microbial Inactivation Methods
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Charles Pilgrim (14 shared papers)Andrew Haydon (1 shared paper)Kenneth R. Thomson (1 shared paper)Samantha Ellis (1 shared paper)Helen Kavnoudias (1 shared paper)Christine Ball (1 shared paper)Stuart K. Roberts (1 shared paper)Wa Cheung (1 shared paper)
- Journals
- HPB (6 papers)ANZ Journal of Surgery (5 papers)Experimental Cell Research (2 papers)Nature (2 papers)European Journal of Surgical Oncology (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Peter Evans
40 papers receiving 974 citations
Peter Evans's Hit Papers
Peers
Comparison fields: 5 of 118
- Biotechnology 283
- Hepatology 136
- Physiology 53
- Gastroenterology 57
- Oncology 235
Countries citing papers authored by Peter Evans
This map shows the geographic impact of Peter Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Evans more than expected).
Fields of papers citing papers by Peter Evans
This network shows the impact of papers produced by Peter Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Evans. The network helps show where Peter Evans may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Investigation of the Safety of Irreversible Electroporation in Humans Hit paper breakdown → | 2011 | 355 |
| 2 | 1998 | 101 | |
| 3 | 1998 | 49 | |
| 4 | 2009 | 41 | |
| 5 | 1998 | 38 | |
| 6 | 2006 | 32 | |
| 7 | 2009 | 29 | |
| 8 | 2010 | 27 | |
| 9 | 2019 | 23 | |
| 10 | 2004 | 23 | |
| 11 | 2003 | 22 | |
| 12 | 2009 | 20 | |
| 13 | Primary nonampullary/periampullary adenocarcinoma of the duodenum. | 1998 | 17 |
| 14 | 2020 | 16 | |
| 15 | 2010 | 16 | |
| 16 | 2017 | 16 | |
| 17 | 1997 | 16 | |
| 18 | 1994 | 14 | |
| 19 | 1974 | 14 | |
| 20 | 1995 | 13 |
About Peter Evans
Peter Evans is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Physical and Theoretical Chemistry, having authored 42 papers that have together received 1000 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), thermodynamics and calorimetric analyses (5 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Pancreatitis Pathology and Treatment (4 papers), Gallbladder and Bile Duct Disorders (4 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Biotechnology (283 citations), Hepatology (136 citations), Physiology (53 citations), Gastroenterology (57 citations) and Oncology (235 citations). Peter Evans has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Charles Pilgrim, Andrew Haydon, Kenneth R. Thomson, Samantha Ellis, Helen Kavnoudias, Christine Ball, Stuart K. Roberts, Wa Cheung, Christopher Christophi and Val Usatoff. Their work appears in journals such as HPB, ANZ Journal of Surgery, Experimental Cell Research, Nature and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.